Point72 Asset Management
PRCT icon

Point72 Asset Management’s Procept Biorobotics PRCT Stock Holding History

Point72 Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$285K Hold
11,400
– – ﹤0.01% 3384
2025
Q4 		$359K Buy
+11,400
New +$378K ﹤0.01% 3396
2024
Q1 		– Sell
-100,000
Closed -$4.19M – 2527
2023
Q4 		$4.19M Buy
+100,000
New +$3.41M 0.01% 993

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management's PRCT Position: Q1 2026 in Review

Point72 Asset Management opened a new position in Procept Biorobotics (PRCT) in Q1 2026: 1,128,543 shares worth $28.2M. The stake represents 0.04% of the portfolio and ranks #637 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in PRCT as recently as Q2 2025.

Point72 Asset Management first reported a position in PRCT in Q3 2021 and has held it in 4 quarters since. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Point72 Asset Management held 1,128,543 shares of Procept Biorobotics worth $28.2M as of Q1 2026.
  • Procept Biorobotics was a new Point72 Asset Management position in Q1 2026.
  • Procept Biorobotics made up 0.04% of Point72 Asset Management's portfolio in Q1 2026, its #637 holding.
  • Point72 Asset Management first reported a position in Procept Biorobotics in Q3 2021 and has held it in 4 quarters since.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.